LEONHARDT HARRY J — SEC Form 4 filings

SEC reporting owner CIK 1286102. 2 Form 4 filings on record with FilingPulse; latest filed 2025-01-08.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2024-03-04 to 2025-01-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Poseida Therapeutics, Inc. (PSTX)GC & Chief Compliance Officer29

Form 4 filings — LEONHARDT HARRY J

FiledFormIssuerReported transactionsSource
2025-01-084Poseida Therapeutics, Inc. (PSTX)Code (U): 223,640 · Disposition to issuer (D): 160,385 (derivative) @ $0 · Disposition to issuer (D): 137,000 (derivative) @ $0 · Disposition to issuer (D): 72,568 (derivative) @ $0 · Disposition to issuer (D): 125,283 (derivative) @ $0 · Disposition to issuer (D): 111,700 (derivative) @ $0EDGAR
2024-03-044Poseida Therapeutics, Inc. (PSTX)Grant/award (A): 80,743 @ $0 · Tax withholding (F): 16,306 @ $4.13 · Grant/award (A): 111,700 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1286102 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →